Western Financial Corporation Regeneron Pharmaceuticals, Inc. Transaction History
Western Financial Corporation
- $143 Million
- Q3 2022
A detailed history of Western Financial Corporation transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Western Financial Corporation holds 963 shares of REGN stock, worth $888,906. This represents 0.46% of its overall portfolio holdings.
Number of Shares
963
Previous 770
25.06%
Holding current value
$888,906
Previous $455,000
45.71%
% of portfolio
0.46%
Previous 0.32%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,481Shares Held
85.5MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$8.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$7.8 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$7.64 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.47 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.28 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $98.9B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...